|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
7 January 2013 |
|
Main ID: |
NCT01132898 |
|
Date of registration:
|
27/05/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Long-term Clinical Correlates of Traumatic Brain Injury
|
|
Scientific title:
|
Long Term Clinical Correlates of TBI: Imaging, Biomarkers, and Clinical Phenotyping Parameters |
|
Date of first enrolment:
|
May 2010 |
|
Target sample size:
|
300 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01132898 |
|
Study type:
|
Observational |
|
Study design:
|
Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) |
|
Address:
|
|
|
Telephone:
|
800-411-1222 |
|
Email:
|
prpl@mail.cc.nih.gov |
|
Affiliation:
|
|
|
|
Name:
|
Andre J Van Der Merwe |
|
Address:
|
|
|
Telephone:
|
(301) 496-4733 |
|
Email:
|
andre.vandermerwe@nih.gov |
|
Affiliation:
|
|
|
|
Name:
|
Leighton Chan, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National Institutes of Health Clinical Center (CC) |
|
|
Key inclusion & exclusion criteria
|
- INCLUSION CRITERIA:
Subjects eligible for participation in the prospective cohort must meet the following inclusion criteria:
Diagnosis of non-penetrating mild, moderate, or severe TBI
Injury occurred less than one year before enrollment
Age 18 years of age and older
Able to provide informed consent or with a legally-authorized representative able to provide consent
Any subject enrolled in Dr. Latour's acute TBI protocol (10-N-N122) meeting inclusion/exclusion criteria of this protocol
Any subject who initially enrolls in the cross-sectional sub-study, but subsequently agrees to subsequent evaluations
Subjects eligible for participation in the cross-sectional sub-study must meet the following inclusion criteria:
Diagnosis of non-penetrating mild, moderate, or severe TBI
Injury occurred less than five years before enrollment
Age 18 years of age and older
Able to provide informed consent or with a legally-authorized representative able to provide consent
EXCLUSION CRITERIA:
Subjects are not eligible for participation in the prospective cohort if any of the following conditions exist:
Contraindication to MRI scanning including certain metal implants or devices such as: cardiac pacemaker, insulin infusion pump, implanted drug infusion device, cochlear, otologic, or ear implant, transdermal medication patch (Nitroglycerine) that cannot be removed for the study, body piercing(s), bone/joint pin, screw, nail, plate, wire sutures or surgical staples, shunts, cerebral aneurysms clips, shrapnel or other metal imbedded in a patient's body (such as from war wounds or accidents or previous work in metal fields or machines that may have left any metallic fragments in or near the patient's eyes).
Multiple trauma or accidents in the past with non-certainty that metal objects are still present in the body
Conditions precluding entry into the scanners (e.g. morbid obesity, claustrophobia, etc.).
Pregnant women.
Women who are breast-feeding may enroll in the study, but will not receive PET-CT.
Inability to read or speak enough English to complete the clinical phenotyping testing.
Medical or Psychological instability such that the subject could not reasonably be expected to fulfill the study requirements.
Penetrating head injury.
Subjects are not eligible for participation in the cross-sectional sub-study if any of the following conditions exist:
Contraindication to MRI scanning including certain metal implants or devices such as: cardiac pacemaker, insulin infusion pump, implanted drug infusion device, cochlear, otologic, or ear implant, transdermal medication patch (Nitroglycerine) that cannot be removed for the study, body piercing(s), bone/joint pin, screw, nail, plate, wire sutures or surgical staples, shunts, cerebral aneurysms clips, shrapnel or other metal imbedded in a patient's body (such as from war wounds or accidents or previous work in metal fields or machines that may have left any metallic fragments in or near the patient's eyes).
Multiple trauma or accidents in the past with non-certainty that metal objects are still present in the body
Conditions precluding entry into the scanners (e.g. morbid obesity, claustrophobia, etc.).
Pregnant women.
Inability to read or speak enough English to complete the clinical phenotyping testing.
Medical or Psychological instability such that the subject could not reasonably be expected to fulfill the study requirements.
Penetrating head injury.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Traumatic Brain Injury
|
|
Secondary ID(s)
|
|
10-CC-0118
|
|
100118
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|